NEA Management Company’s Clovis Oncology, Inc. CLVS Stock Holding History

NEA Management Company’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,139,890	Closed	-$50.6M	–	40
2016 Q4	$50.6M	Hold	1,139,890	–	–	2.01%	11
2016 Q3	$41.1M	Hold	1,139,890	–	–	1.84%	12
2016 Q2	$15.6M	Hold	1,139,890	–	–	0.81%	19
2016 Q1	$21.9M	Hold	1,139,890	–	–	1.45%	16
2015 Q4	$39.9M	Hold	1,139,890	–	–	2.54%	11
2015 Q3	$105M	Hold	1,139,890	–	–	6.91%	5
2015 Q2	$100M	Sell	1,139,890 -1,139,891	-50%	-$97.6M	5.23%	7
2015 Q1	$169M	Hold	2,279,781	–	–	7.65%	3
2014 Q4	$128M	Hold	2,279,781	–	–	6.19%	4
2014 Q3	$103M	Hold	2,279,781	–	–	5.26%	6
2014 Q2	$94.4M	Hold	2,279,781	–	–	4.43%	7
2014 Q1	$158M	Hold	2,279,781	–	–	7.75%	4
2013 Q4	$137M	Hold	2,279,781	–	–	6.64%	4
2013 Q3	$139M	Hold	2,279,781	–	–	5.49%	6
2013 Q2	$153M	Buy	+2,279,781	New	+$103M	6.82%	4

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

NEA Management Company's CLVS Position: Q1 2017 in Review

NEA Management Company sold out of Clovis Oncology, Inc. (CLVS) in Q1 2017, closing a stake of 1,139,890 shares — an estimated $50.6M sold.

NEA Management Company first reported a position in CLVS in Q2 2013 and held it in 15 quarters. The position peaked at $169M in Q1 2015. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2017.

NEA Management Company reported no remaining Clovis Oncology, Inc. position as of Q1 2017 after selling out during the quarter.
NEA Management Company sold 1,139,890 Clovis Oncology, Inc. shares in Q1 2017, an estimated $50.6M.
NEA Management Company first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 15 quarters.
NEA Management Company's Clovis Oncology, Inc. position peaked at $169M in Q1 2015.
229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2017.

Based on NEA Management Company's 13F filing for Q1 2017, filed 10 May 2017.